Regulation of the Key Epithelial Cancer Suppressor miR-124 Function by Competing Endogenous RNAs

Eleonora A Braga1,2, Marina V Fridman3, Alexey M Burdennyy1

  • 1Institute of General Pathology and Pathophysiology, 125315 Moscow, Russia.

Insights

MicroRNA-124 (miR-124) acts as a tumor suppressor by inhibiting oncogenic proteins in epithelial cancers. Its dysregulation involves epigenetic changes and interactions with long non-coding RNAs and circular RNAs, offering therapeutic potential.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • MicroRNA-124 (miR-124) expression is decreased in various epithelial cancers, where it functions as a tumor suppressor.
  • miR-124 inhibits the translation of multiple oncogenic proteins, playing a critical role in cancer progression.

Purpose of the Study:

  • To investigate the regulatory mechanisms of miR-124 expression in epithelial cancers.
  • To explore the role of competing endogenous RNAs (ceRNAs) involving long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs) in miR-124-mediated cancer pathways.
  • To identify potential therapeutic targets based on miR-124 interactions.

Main Methods:

  • Bioinformatic analysis and literature review to identify lncRNA/miR-124/mRNA and circRNA/miR-124/mRNA interactions (ceRNA networks).
  • Analysis of identified axes for involvement in cancer hallmarks like epithelial-mesenchymal transition (EMT), metastasis, signaling pathways, and patient outcomes.
  • Review of studies detailing miR-124 regulation by circRNAs, including circHIPK3.

Main Results:

  • Epigenetic mechanisms, including gene hypermethylation and ceRNA networks, significantly regulate miR-124 expression.
  • Over 40 lncRNA/miR-124/mRNA interactomes were identified, with MALAT1, NEAT1, HOXA11-AS, and XIST being prominent.
  • Specific axes are linked to EMT, metastasis, key cancer signaling pathways (Wnt/β-catenin, TGF-β, etc.), stemness, impaired survival, and chemoresistance.
  • 14 circRNA regulations of miR-124 were found, with circHIPK3 implicated in proliferation, EMT, and drug resistance.

Conclusions:

  • Dysregulation of miR-124, influenced by epigenetic factors and complex ceRNA networks, is crucial in epithelial cancers.
  • Identified miR-124 interacting partners and pathways represent promising therapeutic targets for cancer treatment.
  • Further research into miR-124-based therapies holds significant potential for improving patient outcomes.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.3K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.5K
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
976